Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Raising hemoglobin level with erythropoietin improves cerebral but not muscle tissue oxygenation in patients with sickle cell disease

Nelly Kiriza, Lara Abdelmohsen, Elizabeth Meinert-Spyker, John Tukakira, Feyisayo Oluwole, Adeniyi Adiat, Joel Dzidzorvi Kwame Disu, Nahom Mossazghi, Jude Jonassaint, D. Akinsanya Olesugun-Joseph, Vincent Osunkalu, Olubusola Oluwole, Laura DeCastro, Enrico Novelli, Titilope Adeyemo, Sossena Wood, Julia Xu

Blood (2025) 146 (Supplement 1): 2964.

https://doi.org/10.1182/blood-2025-2964

Published: 2025

Journal Articles

Cerebral and peripheral microvascular function in sickle cell disease: Blood flow and oxygen extraction via diffuse correlation and Near-Infrared spectroscopy

Dheemant Jallepalli, Siddhartho Roy, Elizabeth Meinert-Spyker, Julia Xu, Sossena Wood

Blood (2025) 146 (Supplement 1): 2937.

https://doi.org/10.1182/blood-2025-2937

Published: 2025

Journal Articles

EPO treatment in combination with hydroxyurea improves pain and other quality of life measures in sickle cell disease

Kseniya Anishchenko, Nelly Kiriza, Feyisayo Oluwole, Adeniyi Adiat, John Tukakira, Jude Jonassaint, D. Akinsanya Olesugun-Joseph, Vincent Osunkalu, Olubusola Oluwole, Laura DeCastro, Enrico Novelli, Titilope Adeyemo, Julia Xu

Blood (2025) 146 (Supplement 1): 614.

https://doi.org/10.1182/blood-2025-614

Published: 2025

Journal Articles

Sex-related differences in silent cerebral infarction burden among adults with sickle cell disease

Sally Momoh, John Tukakira, Elizabeth Meinert-Spyker, Leticia Candra, Tamer Ibrahim, Enrico Novelli, Minjie Wu, Sossena Wood, Julia Xu

Blood (2025) 146 (Supplement 1): 1193.

https://doi.org/10.1182/blood-2025-1193

Published: 2025

Journal Articles

Daprodustat Induces Fetal Hemoglobin and Erythropoietic Drive in an in Vitro and In Vivo Model of Sickle Cell Disease

Malini Sharma, Fabliha Ahmed Chowdhury, Stefanie Taiclet, Brian J Philips, Katherine C Wood, Adam C Straub, Julia Xu

Blood (2024) 144 (Supplement 1): 1111.

https://doi.org/10.1182/blood-2024-209205

Published: 2024

Journal Articles

Dynamic Cerebral Autoregulation and Blood Pressure Oscillations Reveal the Severity of Autoregulatory Dysfunction in Sickle Cell Disease

Joel Dzidzorvi Kwame Disu, Lara Abdelmohsen, Nahom Mossazghi, Elizabeth Meinert-Spyker, Christine Saber, Julia Xu, Sossena Wood

Blood (2024) 144 (Supplement 1): 3876.

https://doi.org/10.1182/blood-2024-210312

Published: 2024

Journal Articles

Assessing the Impact of Cognitive Load on Resting State Tissue Oxygen Saturation in Adult Patients with Sickle Cell Disease

Lara Abdelmohsen, Nahom Mossazghi, Shidhartho Roy, Joel Dzidzorvi Kwame Disu, Elizabeth Meinert-Spyker, Christine Saber, Julia Xu, Sossena Wood

Blood (2024) 144 (Supplement 1): 3879.

https://doi.org/10.1182/blood-2024-208977

Published: 2024

Journal Articles

Anti-Hemojuvelin Monoclonal Antibody Reverses Anemia and Exerts Disease-Modifying Effects in a Mouse Model of Inflammatory Bowel Disease

Julia Xu, Brian MacDonald, Min Wu

Blood (2024) 144 (Supplement 1): 3849.

https://doi.org/10.1182/blood-2024-205343

Published: 2024

Journal Articles

Higher Hemoglobin Level Correlates with Increased Tissue Oxygenation in a Comprehensive Profile of Hemorheology in Sickle Cell Disease

Christine Saber, Elizabeth Meinert-Spyker, Lara Abdelmohsen, Brian J Philips, Joel Dzidzorvi Kwame Disu, Nahom Mossazghi, Nelly Kiriza, Seyed Mehdi Nouraie, Olubusola Oluwole, Laura M. DeCastro, Adam C Straub, Enrico M Novelli, Sossena Wood, Julia Xu

Blood (2024) 144 (Supplement 1): 294.

https://doi.org/10.1182/blood-2024-203346

Published: 2024

Journal Articles

Anti-Hemojuvelin Monoclonal Antibody Alleviated Anemia Induced By Ruxolitinib Treatment in Mice

Julia Xu, Brian MacDonald, John Quisel, Min Wu

Blood (2024) 144 (Supplement 1): 1752.

https://doi.org/10.1182/blood-2024-207686

Published: 2024

Journal Articles

Predicting Hemoglobin Response to Hydroxyurea and Voxelotor in Adults with Sickle Cell Disease

Christine Saber, Rashmi Madhukar, Olubusola Oluwole, Laura M. Decastro, Enrico M Novelli, Julia Xu

Blood (2023) 142 (Supplement 1): 3895.

https://doi.org/10.1182/blood-2023-174487

Published: 2023

Journal Articles

Long-Term Safety and Efficacy of Mitapivat, an Oral Pyruvate Kinase Activator, in Adults with Sickle Cell Disease: Extension of a Phase 1 Dose Escalation Study

Anna Conrey, Ingrid Frey, Nancy Asomaning, Ruth Pierre Charles, Dina Parekh, Julia Xu, Kang Le, Britney Kruah, Quan Li, Emily Dunkelberger, Troy Cellmer, Amber M Yates, Megan Wind-Rotolo, Neal Jeffries, William A Eaton, Swee Lay Thein

Blood (2023) 142 (Supplement 1): 273.

https://doi.org/10.1182/blood-2023-180165

Published: 2023

Journal Articles

Patients, Parents and Providers Perspectives Toward Treatment Options for Sickle Cell Disease

Christopher Wanjiku, Cyrus Githinji Njuguna, David Lazris, Julia Xu, Festus Njuguna, Austin Okuku, Katherine MacDonald

Blood (2023) 142 (Supplement 1): 3679.

https://doi.org/10.1182/blood-2023-191194

Published: 2023

Journal Articles

Addressing Chronic Anemia in Sickle Cell Disease: Characterizing Erythropoiesis-Stimulating Agent (ESA) Utilization and Practice Patterns Among Providers

Iuliia Kovalenko, Mitali Shah, Nelly Kiriza, Enrico M Novelli, Laura M. Decastro, Julia Xu

Blood (2023) 142 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2023-180334

Published: 2023

Journal Articles

Longitudinal Characterization of Hemodynamic Changes with Multimodal Optical Techniques in Patients with Sickle Cell Disease Treated with Mitapivat

Timothy Quang, Ingrid Frey, Julia Xu, Golnar Mostashari, Anna Conrey, Dina S. Parekh, Ruth Pierre Charles, Brian Hill, Swee Lay Thein, Bruce J Tromberg

Blood (2023) 142 (Supplement 1): 2492.

https://doi.org/10.1182/blood-2023-174227

Published: 2023

Journal Articles

The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications

Lindsay Mize, RN, MSN, CPNP, Shelly Burgett, RN, MSN, FNP, Julia Xu, MD, Jennifer Rothman, MD, Nirmish Shah, MD

Blood (2014) 124 (21): 4934.

https://doi.org/10.1182/blood.V124.21.4934.4934

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Raising hemoglobin level with erythropoietin improves cerebral but not muscle tissue oxygenation in patients with sickle cell disease

Cerebral and peripheral microvascular function in sickle cell disease: Blood flow and oxygen extraction via diffuse correlation and Near-Infrared spectroscopy

EPO treatment in combination with hydroxyurea improves pain and other quality of life measures in sickle cell disease

Sex-related differences in silent cerebral infarction burden among adults with sickle cell disease

Daprodustat Induces Fetal Hemoglobin and Erythropoietic Drive in an in Vitro and In Vivo Model of Sickle Cell Disease

Dynamic Cerebral Autoregulation and Blood Pressure Oscillations Reveal the Severity of Autoregulatory Dysfunction in Sickle Cell Disease

Assessing the Impact of Cognitive Load on Resting State Tissue Oxygen Saturation in Adult Patients with Sickle Cell Disease

Anti-Hemojuvelin Monoclonal Antibody Reverses Anemia and Exerts Disease-Modifying Effects in a Mouse Model of Inflammatory Bowel Disease

Higher Hemoglobin Level Correlates with Increased Tissue Oxygenation in a Comprehensive Profile of Hemorheology in Sickle Cell Disease

Anti-Hemojuvelin Monoclonal Antibody Alleviated Anemia Induced By Ruxolitinib Treatment in Mice

Predicting Hemoglobin Response to Hydroxyurea and Voxelotor in Adults with Sickle Cell Disease

Long-Term Safety and Efficacy of Mitapivat, an Oral Pyruvate Kinase Activator, in Adults with Sickle Cell Disease: Extension of a Phase 1 Dose Escalation Study

Patients, Parents and Providers Perspectives Toward Treatment Options for Sickle Cell Disease

Addressing Chronic Anemia in Sickle Cell Disease: Characterizing Erythropoiesis-Stimulating Agent (ESA) Utilization and Practice Patterns Among Providers

Longitudinal Characterization of Hemodynamic Changes with Multimodal Optical Techniques in Patients with Sickle Cell Disease Treated with Mitapivat

The Use of Chronic Transfusions in Sickle Cell Disease for Non-Stroke Related Indications

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only